Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Krystal Biotech Inc (NQ: KRYS )

157.25 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 157.25
Bid (Size) 157.50 (2)
Ask (Size) 200.00 (2)
Prev. Close 157.25
Today's Range 157.25 - 157.25
52wk Range 82.09 - 189.97
Shares Outstanding 22,205,642
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
Don’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year. 
Via InvestorPlace
(KRYS) - Analyzing Krystal Biotech's Short Interest
Via Benzinga

Performance

YTD
+25.84%
+25.84%
1 Month
-7.21%
-7.21%
3 Month
+20.03%
+20.03%
6 Month
+39.95%
+39.95%
1 Year
+85.00%
+85.00%

More News

Read More
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today
Via Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,400 Today
Via Benzinga
Krystal Biotech Inc. (NASDAQ: KRYS) is a Leading Gainer in 2/26 Morning Trading
Via Investor Brand Network
A Preview Of Krystal Biotech's Earnings
Via Benzinga
Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results
Via Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Expert Ratings for Krystal Biotech
Via Benzinga
This Stock Has Quadrupled in 5 Years. Can It Do It Again?
Via The Motley Fool
Earnings Scheduled For November 6, 2023
Via Benzinga
A Preview Of Krystal Biotech's Earnings
Via Benzinga
Earnings Scheduled For February 26, 2024
Via Benzinga
5 Analysts Have This to Say About Krystal Biotech
Via Benzinga
5 Analysts Have This to Say About Krystal Biotech
Via Benzinga
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Via Investor's Business Daily
Exposures Product Safety
Krystal Biotech Sells Rare Pediatric Disease Priority Review Voucher For $100M
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.